EA
Emerald Advisors’s Pfizer PFE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $283K | Sell |
11,685
-19,938
| -63% | -$483K | 0.04% | 89 |
|
|
2025
Q1 | $801K | Buy |
31,623
+3,149
| +11% | +$79.8K | 0.11% | 47 |
|
|
2024
Q4 | $755K | Buy |
28,474
+2,190
| +8% | +$58.1K | 0.1% | 50 |
|
|
2024
Q3 | $768K | Buy |
26,284
+1,135
| +5% | +$33.2K | 0.11% | 47 |
|
|
2024
Q2 | $704K | Buy |
25,149
+5,544
| +28% | +$155K | 0.11% | 48 |
|
|
2024
Q1 | $544K | Buy |
19,605
+3,138
| +19% | +$87.1K | 0.1% | 57 |
|
|
2023
Q4 | $474K | Sell |
16,467
-4,140
| -20% | -$119K | 0.09% | 55 |
|
|
2023
Q3 | $684K | Buy |
20,607
+4,895
| +31% | +$162K | 0.16% | 37 |
|
|
2023
Q2 | $576K | Buy |
15,712
+1,443
| +10% | +$52.9K | 0.14% | 42 |
|
|
2023
Q1 | $582K | Buy |
14,269
+512
| +4% | +$20.9K | 0.15% | 39 |
|
|
2022
Q4 | $705K | Sell |
13,757
-665
| -5% | -$34.1K | 0.2% | 31 |
|
|
2022
Q3 | $631K | Buy |
14,422
+575
| +4% | +$25.2K | 0.18% | 36 |
|
|
2022
Q2 | $726K | Buy |
13,847
+682
| +5% | +$35.8K | 0.2% | 34 |
|
|
2022
Q1 | $682K | Buy |
13,165
+465
| +4% | +$24.1K | 0.16% | 36 |
|
|
2021
Q4 | $750K | Buy |
12,700
+1,750
| +16% | +$103K | 0.18% | 32 |
|
|
2021
Q3 | $471K | Buy |
10,950
+170
| +2% | +$7.31K | 0.13% | 59 |
|
|
2021
Q2 | $422K | Buy |
10,780
+688
| +7% | +$26.9K | 0.13% | 63 |
|
|
2021
Q1 | $366K | Buy |
10,092
+165
| +2% | +$5.98K | 0.13% | 57 |
|
|
2020
Q4 | $365K | Sell |
9,927
-1,923
| -16% | -$70.7K | 0.13% | 55 |
|
|
2020
Q3 | $435K | Buy |
11,850
+341
| +3% | +$12.5K | 0.17% | 44 |
|
|
2020
Q2 | $376K | Sell |
11,509
-330
| -3% | -$10.8K | 0.17% | 51 |
|
|
2020
Q1 | $441K | Sell |
11,839
-5,007
| -30% | -$187K | 0.2% | 37 |
|
|
2019
Q4 | $677K | Buy |
+16,846
| New | +$677K | 0.65% | 21 |
|